Nolla Health 获美国犹他州监管批准，可让 AI 为符合条件的痤疮病例完成初始处方流程。AI 负责信息采集、皮肤扫描、评估、处方和随访，必要时由临床人员介入。批准范围限于成人轻中度痤疮和指定外用乳膏、凝胶，处方转交持证药剂师，早期病例由医师逐例审核后再逐步降低监督强度。
Healthcare is probably AI's highest-stakes real-world test.
Most consumer health AI ends in the same spot: a suggestion and a prompt to book an appointment.
@nollahealth now takes eligible acne cases in Utah all the way through.
The AI handles intake, a skin scan, assessment, the prescription and follow-up, and a clinician steps in when needed.
Plenty of models can label acne in a photo. None in the U.S. had been cleared to write a first prescription.
What Utah signed off on is the structure around Nolla's model: adults only, mild to moderate acne, a set list of topical creams and gels, prescriptions routed to a licensed pharmacist, and physicians reviewing every early case before oversight steps down.
Today, Nolla Health became the first organization in the U.S. (and possibly the world) to receive regulatory approval for an AI to issue initial prescriptions. This makes Nolla the first ever actual end-to-end AI doctor.在 X 查看被引用的帖子
来源：Rohan Paul · x.com